• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因造血干细胞移植受者中针对碳青霉烯类耐药肠杆菌科定植的串联粪便微生物移植周期:一例病例报告及文献复习。

Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.

机构信息

Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, China.

Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.

出版信息

Eur J Med Res. 2021 Apr 28;26(1):37. doi: 10.1186/s40001-021-00508-8.

DOI:10.1186/s40001-021-00508-8
PMID:33910622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8080403/
Abstract

BACKGROUND

Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with high non-relapse mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Also, intestinal CRE colonization is a risk factor for subsequent CRE infection. Several clinical studies have reported successful fecal microbiota transplantation (FMT) for the gut decontamination of a variety of multidrug-resistant bacteria (MDRB), even in immunosuppressed patients. Similarly, other studies have also indicated that multiple FMTs may increase or lead to successful therapeutic outcomes.

CASE PRESENTATION

We report CRE colonization in an allo-HSCT patient with recurrent CRE infections, and its successful eradication using tandem FMT cycles at 488 days after allo-HSCT. We also performed a comprehensive microbiota analysis. No acute or delayed adverse events (AEs) were observed. The patient remained clinically stable with CRE-negative stool culture at 26-month follow-up. Our analyses also showed some gut microbiota reconstruction. We also reviewed the current literature on decolonization strategies for CRE.

CONCLUSIONS

CRE colonization led to a high no-relapse mortality after allo-HSCT; however, well-established decolonization strategies are currently lacking. The successful decolonization of this patient suggests that multiple FMT cycles may be potential options for CRE decolonization.

摘要

背景

由于抗生素选择有限,碳青霉烯类耐药肠杆菌科(CRE)感染与异基因造血干细胞移植(allo-HSCT)后非复发死亡率高有关。此外,肠道 CRE 定植是随后发生 CRE 感染的危险因素。几项临床研究报告了粪便微生物群移植(FMT)在多种多药耐药菌(MDRB)肠道去污染方面的成功应用,即使在免疫抑制患者中也是如此。同样,其他研究也表明,多次 FMT 可能会增加或导致成功的治疗结果。

病例介绍

我们报告了一例 allo-HSCT 患者在 allo-HSCT 后 488 天出现复发性 CRE 感染和 CRE 定植,使用串联 FMT 周期成功清除。我们还进行了全面的微生物组分析。未观察到急性或迟发性不良事件(AE)。在 26 个月的随访中,患者仍保持临床稳定,CRE 粪便培养阴性。我们的分析还显示了一些肠道微生物组的重建。我们还回顾了目前关于 CRE 去定植策略的文献。

结论

allo-HSCT 后 CRE 定植导致非复发死亡率高;然而,目前缺乏成熟的去定植策略。该患者成功去定植表明,多次 FMT 周期可能是 CRE 去定植的潜在选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ba/8080403/de1581224de8/40001_2021_508_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ba/8080403/820851de2b41/40001_2021_508_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ba/8080403/df806d6ddc92/40001_2021_508_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ba/8080403/de1581224de8/40001_2021_508_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ba/8080403/820851de2b41/40001_2021_508_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ba/8080403/df806d6ddc92/40001_2021_508_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ba/8080403/de1581224de8/40001_2021_508_Fig3_HTML.jpg

相似文献

1
Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.异基因造血干细胞移植受者中针对碳青霉烯类耐药肠杆菌科定植的串联粪便微生物移植周期:一例病例报告及文献复习。
Eur J Med Res. 2021 Apr 28;26(1):37. doi: 10.1186/s40001-021-00508-8.
2
Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.粪便微生物移植后耐碳青霉烯类肠杆菌科与耐万古霉素肠球菌定植清除的比较:一项前瞻性对照研究。
J Hosp Infect. 2018 Aug;99(4):481-486. doi: 10.1016/j.jhin.2018.02.018. Epub 2018 Mar 2.
3
Fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae: A systematic review.粪便微生物群移植治疗耐碳青霉烯类肠杆菌科细菌感染:系统评价。
J Infect. 2022 Jun;84(6):749-759. doi: 10.1016/j.jinf.2022.04.028. Epub 2022 Apr 21.
4
Intestinal Dysbiosis in Carriers of Carbapenem-Resistant .携带碳青霉烯类耐药菌的肠道菌群失调
mSphere. 2020 Apr 29;5(2):e00173-20. doi: 10.1128/mSphere.00173-20.
5
Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities.粪便微生物群移植可缩短定植期,使携带产碳青霉烯酶细菌的患者重新进入医疗保健机构。
Int J Antimicrob Agents. 2019 Apr;53(4):355-361. doi: 10.1016/j.ijantimicag.2018.11.014. Epub 2018 Nov 23.
6
Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing Enterobacteriaceae: a proof of principle study.粪菌移植用于对抗产超广谱β-内酰胺酶肠杆菌科细菌的肠道定植:一项原理验证研究
BMC Res Notes. 2018 Mar 22;11(1):190. doi: 10.1186/s13104-018-3293-x.
7
Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?粪便微生物群移植是根除高度耐药性肠道细菌携带的一种选择吗?
J Hosp Infect. 2017 Apr;95(4):433-437. doi: 10.1016/j.jhin.2017.02.001. Epub 2017 Feb 6.
8
Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage.产超广谱β-内酰胺酶或碳青霉烯酶肠杆菌科肠道定植的清除策略。
Expert Rev Anti Infect Ther. 2019 Aug;17(8):557-569. doi: 10.1080/14787210.2019.1645007. Epub 2019 Jul 25.
9
Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation.粪便微生物移植可减轻接受异基因造血细胞移植的多重耐药菌定植患者的不良结局。
Front Cell Infect Microbiol. 2021 Aug 27;11:684659. doi: 10.3389/fcimb.2021.684659. eCollection 2021.
10
Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.粪便微生物群移植治疗肠道类固醇耐药移植物抗宿主病:两例病例报告及文献复习。
J Int Med Res. 2020 Jun;48(6):300060520925693. doi: 10.1177/0300060520925693.

引用本文的文献

1
Fecal Microbiota Transfer in Acute Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation.异基因干细胞移植后急性移植物抗宿主病中的粪便微生物群移植
Visc Med. 2024 Mar 26;40(4):1-6. doi: 10.1159/000538303.
2
VirBR, a transcription regulator, promotes IncX3 plasmid transmission, and persistence of bla in zoonotic bacteria.VirBR,一种转录调控因子,促进 IncX3 质粒的传播和 bla 在人畜共患病细菌中的持续存在。
Nat Commun. 2024 Jun 28;15(1):5498. doi: 10.1038/s41467-024-49800-1.
3
Risk Factors for Carbapenem-Resistant Colonization and the Effect on Clinical Outcomes and Prognosis in Allogeneic Hematopoietic Stem Cell Transplanted Patients.

本文引用的文献

1
Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.在开放标签的PUNCH CD研究中,微生物群恢复可减少复发性艰难梭菌感染患者肠道中耐抗生素细菌的定植。
Genome Med. 2021 Feb 16;13(1):28. doi: 10.1186/s13073-021-00843-9.
2
Alteration of Gut Microbiota in Carbapenem-Resistant Enterobacteriaceae Carriers during Fecal Microbiota Transplantation According to Decolonization Periods.根据去定植时期,粪便微生物群移植期间耐碳青霉烯类肠杆菌科细菌携带者肠道微生物群的变化
Microorganisms. 2021 Feb 10;9(2):352. doi: 10.3390/microorganisms9020352.
3
异基因造血干细胞移植患者耐碳青霉烯定植的危险因素及其对临床结局和预后的影响
Infect Drug Resist. 2023 Oct 25;16:6821-6831. doi: 10.2147/IDR.S424048. eCollection 2023.
4
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting.粪便微生物群移植在异基因干细胞移植环境中的作用。
Microorganisms. 2023 Aug 29;11(9):2182. doi: 10.3390/microorganisms11092182.
5
Role of Gut Microbiota and Oxidative Stress in the Progression of Transplant-Related Complications following Hematopoietic Stem Cell Transplantation.肠道微生物群和氧化应激在造血干细胞移植后移植相关并发症进展中的作用。
Oxid Med Cell Longev. 2023 Apr 18;2023:3532756. doi: 10.1155/2023/3532756. eCollection 2023.
6
Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients.造血干细胞移植受者中碳青霉烯类耐药革兰氏阴性菌的流行病学、抗菌药物耐药性和死亡危险因素。
Front Cell Infect Microbiol. 2023 Jan 13;12:1098856. doi: 10.3389/fcimb.2022.1098856. eCollection 2022.
7
The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases.粪便(或肠道)微生物群移植在控制传染病中的潜在应用。
Gut Microbes. 2022 Jan-Dec;14(1):2038856. doi: 10.1080/19490976.2022.2038856.
Fecal microbiota transplantation in patients with acute and chronic graft-versus-host disease-spectrum of responses and safety profile. Results from a prospective, multicenter study.
急性和慢性移植物抗宿主病患者的粪便微生物群移植——反应谱和安全性概况。一项前瞻性多中心研究的结果
Am J Hematol. 2021 Mar 1;96(3):E88-E91. doi: 10.1002/ajh.26077. Epub 2021 Jan 13.
4
Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020.系统评价:2000 年至 2020 年粪便微生物群移植相关不良事件的全球发生率。
Aliment Pharmacol Ther. 2021 Jan;53(1):33-42. doi: 10.1111/apt.16148. Epub 2020 Nov 7.
5
Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: gut microbiota profiling, infectious and clinical outcomes.在五名儿科患者异基因造血干细胞移植前通过粪便微生物群移植对多重耐药菌进行去定植:肠道微生物群分析、感染情况及临床结果
Haematologica. 2020 Nov 1;105(11):2686-2690. doi: 10.3324/haematol.2019.244210.
6
Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report.使用无关供体粪便微生物群移植胶囊治疗肠道移植物抗宿主病:一例报告。
Medicine (Baltimore). 2020 Sep 18;99(38):e22129. doi: 10.1097/MD.0000000000022129.
7
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.澳大利亚共识声明:临床实践中粪便微生物群移植的监管、生产和使用。
Gut. 2020 May;69(5):801-810. doi: 10.1136/gutjnl-2019-320260. Epub 2020 Feb 11.
8
Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria.肠道微生物组内的组成通量与革兰氏阴性菌血流感染的风险
Clin Infect Dis. 2021 Dec 6;73(11):e4627-e4635. doi: 10.1093/cid/ciaa068.
9
Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening.经洗涤的微生物群移植与手动粪便微生物群移植:临床发现、动物研究和体外筛选。
Protein Cell. 2020 Apr;11(4):251-266. doi: 10.1007/s13238-019-00684-8. Epub 2020 Jan 9.
10
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.在一项随机、双盲、安慰剂对照研究中评估粪便微生物群移植治疗肠易激综合征患者的疗效。
Gut. 2020 May;69(5):859-867. doi: 10.1136/gutjnl-2019-319630. Epub 2019 Dec 18.